Arseus NV (RCUS.BR)
|Market Cap (Mil.):||€1,205.39|
|Shares Outstanding (Mil.):||31.43|
BRUSSELS, Aug 5 - Belgian medical supplies group Arseus said on Tuesday it expected its 2014 profit margins to be higher than last year's, as the group divests its IT business to fully focus on its pharmaceutical supplies unit.
* Turnover of Arseus increases strongly by 34.7 pct to 209.1 million euros
BRUSSELS, July 10 - Belgian medical supplies group Arseus will sell its IT unit Corilus to fully concentrate on medical compounds, Belgian business unit De Tijd wrote on Thursday.
* Arseus NV announces successful us private placement of us$ 185 million
BRUSSELS, April 9 - The largest shareholder in Belgian medical supplies company Arseus has sold its entire stake in a private placement, a larger sale than initially planned.
* Waterland announces results of private placement of its shares in arseus
* Arseus nv arseus : waterland announces a private placement of its shares in arseus
BRUSSELS, April 8 - Belgian medical supply company Arseus repeated its full-year outlook on Tuesday after first quarter growth in line with expectation thanks to acquisitions and strong expansion of its pharmaceutical ingredients business.
* Turnover of Arseus increased by 26.6 pct to 101.3 mln euros
Earnings vs. Estimates
Analyst Research Reports
Arseus NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.